The Role of Magnetic Resonance Imaging in the Positive Diagnosis of Prostate Cancer in Togo
- 1 Urology Department, Aneho Prefectoral Hospital, Aneho, Togo
- 2 Urology Department, Kara Teaching Hospital, Kara, Togo
- 3 Urology Department, Kara Teaching Hospital, Kara, Togo
- 4 Urology Department, Sylvanus Olympio Teaching Hospital, Lomé, Togo
- 5 Urology Department, Sylvanus Olympio Teaching Hospital, Lomé, Togo
- 6 Urology Department, Sylvanus Olympio Teaching Hospital, Lomé, Togo
Abstract
Introduction : Prostate cancer is a major public health issue. Current diagnostic strategies involve MRI. The objective of our study is to assess the usefulness of prostate MRI in our context. Methods: This was a descriptive and analytical study involving retrospective data collection over a three-year period in the urology department of the Sylvanus Olympio University Hospital. We included the records of patients suspected of having prostate cancer who had undergone prostate MRI. We performed a comparative analysis between MRI and biopsy results. Results : The study included 80 cases of prostate MRI. We reported a frequency of MRI requests of 26 cases/year. Using biopsies as a reference, we found a sensitivity of 86%, a specificity of 39%, a PPV of 66%, and an NPV of 68%. There was a statistically significant difference between the presence of suspicious lesions and histological type. There was a statistically significant positive correlation between the PI-RADS score and histological type (p = 0.012). Conclusion : Requests for prostate MRI are increasing in Togo. Its good sensitivity would be useful in guiding prostate biopsies toward suspicious areas to ensure early diagnosis. However, MRI remains an essential test to avoid non-contributory biopsies in patients at low risk of developing prostate cancer.
- Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al . (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA : A Cancer Journal for Clinicians , 71, 209-249. https://doi.org/10.3322/caac.21660
- Lemaitre, L., Rouvière, O., Penna-Renard, R., Villers, A. and Puech, P. (2008) L’IRM du cancer de la prostate: Un changement de paradigme. Journal de Radiologie , 89, 1053-1064. https://doi.org/10.1016/s0221-0363(08)73909-x
- Hu, Q.S., Cheng, S.P., Yuan, C.S. and Jin, C.H. (2024) Recent Research Advances in Imaging of Prostate Cancer. Journal of Biosciences and Medicines , 12, 114-128. https://doi.org/10.4236/jbm.2024.126012
- Puech, P., Sufana-Iancu, A., Renard, B., Villers, A. and Lemaître, L. (2012) Pourquoi et comment détecter le cancer de la prostate en IRM? Journal de Radiologie Diagnostique et Interventionnelle , 93, 291-301. https://doi.org/10.1016/j.jradio.2012.01.011
- Villani, R., Roosendaal, A., Hämmerli, P. and Iselin, C.E. (2020) PSA et IRM: Comment s’en servir de façon raisonnable pour la détection du cancer de la prostate. Urologie in der Praxis , 22, 153-159. https://doi.org/10.1007/s41973-020-00118-7
- Arafa, M.A., Rabah, D.M., Khan, F.K., Farhat, K.H. and Al-Atawi, M.A. (2021) Effectiveness of Magnetic Resonance Imaging-Targeted Biopsy for Detection of Prostate Cancer in Comparison with Systematic Biopsy in Our Countries with Low Prevalence of Prostate Cancer: Our First Experience after 3 Years. Prostate International , 9, 140-144. https://doi.org/10.1016/j.prnil.2021.01.001
- Tengue, K., Kpatcha, T.M., Botcho, G., Leloua, E., Amavi, A.K., Sikpa, K., et al . (2016) Profil épidémiologique, diagnostique, thérapeutique et évolutif du cancer de la prostate au Togo. African Journal of Urology , 22, 76-82. https://doi.org/10.1016/j.afju.2015.06.006
- Amadou, A., Moumouni, D., Assih, K., Sonhaye, L., Darre, T., Kpatcha, T., et al . (2018). Etat des lieux et profil de l’Imagerie par Résonance Magnétique dans l’exploration du cancer de la prostate au Togo. Journal de la recherche scientifique de l ’ Université de Lomé , 19, 361-367.
- Rozet, F., Hennequin, C., Beauval, J.-B., Beuzeboc, P., Cormier, L., Fromont-Hankard, G., et al . (2018) Recommandations françaises du Comité de Cancérologie de l’AFU—Actualisation 2018-2020: Cancer de la prostate. Progrès en Urologie , 28, R81-R132. https://doi.org/10.1016/j.purol.2019.01.007